HSBC, UBS order Hong Kong office changes as COVID cases rise



By Scott Murdoch

HONG KONG, Jan 6 (Reuters) - Banks in Hong Kong including HSBC Holdings Plc HSBA.L and UBS Group AG UBSG.S are taking steps to reduce the number of people at the workplace after having operated at near full capacity for the past few months, as the city faces a spike in COVID-19 cases.

HSBC, which is one of the biggest employers in Hong Kong with about 30,000 people, will maintain a maximum of 50% staff occupancy in its offices from Friday, according to an internal memo seen by Reuters. A spokesperson for HSBC confirmed the memo's content.

Bank of America BAC.N has encouraged its staff to work from home from Jan. 7-24, according to the U.S. bank's internal memo seen by Reuters. A bank spokesman confirmed the contents of the memo that was sent on Thursday.

Earlier, UBS said in a memo to staff that it would split its 2,500 Hong Kong workforce into two groups, with each returning to the workplace on alternate weeks.

The moves come amid worries of a fifth wave of COVID-19 infections in the Asian financial hub. Hong Kong has announced a two-week ban on some inbound flights, slapped curbs on indoor dining and closed swimming pools, bars and other venues.

The city recorded 38 new coronavirus cases on Wednesday Link

Staff at HSBC and UBS have been told to minimise cross floor travel in their offices and not to socialise with members not in their own team, according to the memos.

HSBC, UBS and Bank of America also said staff had to wear masks when not at their desks, according to their memos.

Standard Chartered STAN.L divided its 6,000 workforce Link into teams earlier this week.

Financial institutions in Hong Kong have been operating at almost full capacity for the past few months, unlike most other major centres like New York or London, as the city stuck to a zero-COVID strategy by largely isolating itself from the world.

On Dec. 31, a streak of three months without community cases ended with the first local transmission of the Omicron variant.
Reporting by Scott Murdoch in Hong Kong; Editing by Himani Sarkar and Kim Coghill

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.